Eikon Therapeutics Inc (EIKN) Price Prediction & ForecastEIKNEikon Therapeutics Inc

Alphio's EIKN stock price prediction model matches the current Eikon Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $5.75 (+3.84%). The 1-week path is $5.72 (+3.32%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Eikon Therapeutics is not a good buy right now due to its significant financial losses and negative momentum. The current price is $7.26, with a year-to-date change of -59.67%. The stock has an RSI of 39.195, indicating it is nearing oversold territory but still lacks bullish momentum. The forward P/E ratio is 0, reflecting uncertainty about future earnings, and the most recent earnings report showed a loss of -1.63 per share, slightly worse than the estimate of -1.61. The main risk is the continued negative net income, which totaled -88,409,000 in Q2 2026, indicating ongoing financial struggles.

Eikon Therapeutics Inc (EIKN) last closed at $5.54, losing -0.09%. These facts feed the 1-day and 1-week EIKN price prediction above.